BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20170101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181022
DTEND;VALUE=DATE:20181025
DTSTAMP:20260515T022806
CREATED:20180803T124056Z
LAST-MODIFIED:20180803T124308Z
UID:17024-1540166400-1540425599@www.pharmajournalist.com
SUMMARY:Gene Therapy for Rare Disorders Europe Summit
DESCRIPTION:2018 is the year gene therapies come into their own. After decades on unfulfilled potential\, this space is gaining tangible momentum\, particularly in addressing the significant unmet need in a range of rare diseases. \n \nGene Therapy for Rare Disorders Europe is the uniquely focused conference uniting industry leaders to discuss the late-stage challenges that need to be overcome to deliver more gene therapies to market. \nRather than early stage basic science\, this meeting is solely devoted to addressing the latest clinical\, manufacturing\, regulatory and commercialization challenges facing this rapidly evolving field. This is a comprehensive guide to define your commercial path forward. Visit the website to see the full agenda\, speaker line-up\, registration costs and more: https://bit.ly/2KoxFys \nClaim a special 10% discount when you quote 9709PJ1 at the checkout. \nContact:\n+44 (0)20 3141 8700\ninfo@hansonwade.com
URL:https://www.pharmajournalist.com/event/gene-therapy-for-rare-disorders-europe-summit/
LOCATION:Novotel London West\, London
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181022
DTEND;VALUE=DATE:20181025
DTSTAMP:20260515T022806
CREATED:20180808T114904Z
LAST-MODIFIED:20180808T114904Z
UID:17066-1540166400-1540425599@www.pharmajournalist.com
SUMMARY:Precision CRISPR Drug Discovery and Gene Therapy Congress 2018
DESCRIPTION:Precision CRISPR Congress\, 22-24 October 2018 | London\, UK is a meeting dedicated to supporting pharma and biotech community in realising the drug discovery and gene therapy applications of optimised CRISPR systems. Joining this community will enable you to hear and share the latest CRISPR advances and help accelerate research that will develop solutions to get CRISPR gene therapy into the clinic faster. \n\n\nWith Cornlab recent move to Switzerland\, meet its Principal Investigator Jacob Corn and learn about Gene Repair in Human Hematopoietic Stem Cells.\nDiscover how to detect in vitro & ex vivo cellular indel profiles and dynamics induced by different CRISPR/Cas9 delivery formats with insights from Eric Paul Bennett\, University of Copenhagen\nFind out how Barry Rosen\, VP\, AstraZeneca is utilising precise genome engineering to empower drug discovery \n\nSounds interesting? Join us this  October in London and be part of a dedicated community in Europe\, striving to realise the drug discovery & gene therapy applications of optimised CRISPR systems. \nTo learn more about this event\, visit http://bit.ly/2AToGpK
URL:https://www.pharmajournalist.com/event/precision-crispr-drug-discovery-and-gene-therapy-congress-2018/
LOCATION:The Hilton London Olympia\, 380 Kensington High St\, Kensington\, London\, W14 8N\, United Kingdom
ORGANIZER;CN="Hanson Wade":MAILTO:tom.hill@crispr-europe.com
END:VEVENT
END:VCALENDAR